Prelude Therapeutics Inc (PRLD) — Total Liabilities
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $72.68M | +65.0% |
| 2024 | $44.06M | +8.6% |
| 2023 | $40.58M | +61.9% |
| 2022 | $25.06M | +30.5% |
| 2021 | $19.20M | +68.3% |
| 2020 | $11.41M | +135.7% |
| 2019 | $4.84M | — |
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $72.68M | +65.0% |
| 2024 | $44.06M | +8.6% |
| 2023 | $40.58M | +61.9% |
| 2022 | $25.06M | +30.5% |
| 2021 | $19.20M | +68.3% |
| 2020 | $11.41M | +135.7% |
| 2019 | $4.84M | — |